How to Reduce Dry Needling Pain in Treatment of Trigger Points of Muscle Triceps Sural in Ankle Post Fracture Patients

Heat or Excesice in Treadmill as Techique to Reduce Dry Needling Pain in Treatment of Trigger Points of Muscle Triceps Sural in Ankle Post Fracture Patients

Ankle fractures are one of the main causes of hospitalization due to injuries in Chile, which also have a discharge and partial load time of approximately 12 weeks in the recovery process. This generates disuse and atrophy of the posterior musculature of the leg called the triceps sural, which makes it difficult to restart and perform the gait. We conducted this research because practically all patients with this type of diagnosis have trigger points in these muscles, and dry needling technique is one of the best for its treatment, but has the disadvantage that it produces post dry needling pain of 48 hours and there is not enough information, or consensus on which method is better to reduce post dry needling pain. This study aims to prove wich technique is most useful in reducing pain post dry needling for the treatment of trigger points in the triceps sural muscle in ankle post fracture patients.

Study Overview

• Status: Terminated
• Conditions: Rehabilitation; Ankle Fractures; Trigger Point Pain, Myofascial; Pain Measurement; Physical Therapy Modalities; Needles
• Intervention / Treatment: Other: Treadmill exercise

• Study Type: Interventional
• Enrollment (Actual): 20
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Chile
  • Santiago, Chile, 8380419
    • Complejo Hospitalario San José

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 60 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Ages between 18 and 60 years of age.
• Man or woman.
• At least one trigger point, active or latent, in the triceps sural muscle of the fractured ankle.
• Perform full load without using technical aids.

Exclusion Criteria:

• Use of analgesics.
• Insurmountable fear of needles.
• Immune disease.
• Clotting disorders.
• Sensory disorders.
• Psychiatric / psychological illness.
• Cancer.
• Rheumatic diseases.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control; Patients remained in the supine position for 20 minutes lying on a stretcher after dry needling.
Experimental: Treadmill; The patients walked on a treadmill for 20 minutes after dry needling, with an inclination of 5 degrees and at a speed at which the perceived exertion was 5 according to the Borg CR10 scale (Chen et al., 2002).	Other: Treadmill exercise; the patients walked on a treadmill for 20 minutes after dry needling, with an inclination of 5 degrees and at a speed at which the perceived exertion was 5 according to the Borg CR10 scale (Chen et al., 2002); Other Names: Treadmill after dry needling

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Perceived pain intensity	Pain will be measured by the Visual Analog Scale for pain (VAS) from 0 to 10, where higher values represent a worse outcome.	Change from baseline (baseline and immediately after treatment)
Ankle Range of Motion (ROM)	It is the degree of angular movement allowed by the ankle joint measured by kinovea.	Change from baseline (baseline and immediately after treatment)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Muscular strength of triceps sural	By means of the heel rise test, the patient must perform a bipodal plantiflexion measured in the maximum number of repetitions in 30 seconds.	Change from baseline (baseline and immediately after treatment)

Collaborators and Investigators

• Sponsor: Becerra, Pablo

Study record dates

Study Major Dates

• Study Start (Actual): August 9, 2018
• Primary Completion (Actual): April 4, 2019
• Study Completion (Actual): April 30, 2019

Study Registration Dates

• First Submitted: January 3, 2022
• First Submitted That Met QC Criteria: January 3, 2022
• First Posted (Actual): January 18, 2022

Study Record Updates

• Last Update Posted (Actual): January 31, 2022
• Last Update Submitted That Met QC Criteria: January 15, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Keywords: Humans; Muscle Strength; Excercise therapy; Hot temperature; Post dry needling; Range of motion, articular
• Additional Relevant MeSH Terms: Wounds and Injuries; Musculoskeletal Diseases; Muscular Diseases; Fractures, Bone; Myofascial Pain Syndromes; Ankle Fractures
• Other Study ID Numbers: Becerra

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No